Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement from the American Heart Association and American College of Cardiology

Circulation

Volumn 132, Issue 22, 2015, Pages e281-e291

  Van Hare, George F ^a   Ackerman, Michael J ^b   Evangelista, Juli Anne K ^c   Kovacs, Richard J ^d   Myerburg, Robert J ^e   Shafer, Keri M ^c   Warnes, Carole A ^f   Washington, Reginald L ^g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MAYO CLINIC   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f MAYO CLINIC ROCHESTER   (United States)

^g Rocky Mountain Hospital For Children Denver   (United States)

Author keywords

AHA Scientific Statements; athletes; cardiovascular abnormalities; congenital heart disease; coronary vessel anomalies; Fontan procedure; transposition of great arteries

Indexed keywords

ALTITUDE; ARTICLE; ATHLETE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FALLOT TETRALOGY; FUNCTIONAL STATUS; HEART CATHETERIZATION; HEART RHYTHM; HEART SURGERY; HEART VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MEDICAL SOCIETY; PERSISTENT PULMONARY HYPERTENSION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR OBSTRUCTIVE DISEASE; SEDENTARY LIFESTYLE; SPORT; TACHYCARDIA; ADVISORY COMMITTEE; CARDIOLOGY; HEART DEFECTS, CONGENITAL; HUMAN; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; ATHLETES; CARDIOLOGY; HEART DEFECTS, CONGENITAL; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84949319743     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000240     Document Type: Article

References (51)

1. Dolk H, Loane MA, Abramsky L, de Walle H, Garne E. Birth prevalence of congenital heart disease. Epidemiology. 2010;21:275-277. doi: 10.1097/EDE.0b013e3181c2979b.
2. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241-2247. doi: 10.1016/j.jacc.2011.08.025.
3. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol. 2005;45:1318-1321. doi: 10.1016/j.jacc.2005.02.006.
4. Hirth A, Reybrouck T, Bjarnason-Wehrens B, Lawrenz W, Hoffmann A. Recommendations for participation in competitive and leisure sports in patients with congenital heart disease: a consensus document. Eur J Cardiovasc Prev Rehabil. 2006;13:293-299.
5. Kobayashi Y, Nakanishi N, Kosakai Y. Pre-and postoperative exercise capacity associated with hemodynamics in adult patients with atrial septal defect: a retrospective study. Eur J Cardiothorac Surg. 1997;11:1062-1066.
6. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334-2351.
7. Möller T, Brun H, Fredriksen PM, Holmstrøm H, Peersen K, Pettersen E, Grünig E, Mereles D, Thaulow E. Right ventricular systolic pressure response during exercise in adolescents born with atrial or ventricular septal defect. Am J Cardiol. 2010;105:1610-1616. doi: 10.1016/j. amjcard.2010.01.024.
8. Bonow RO, Nishimura RA, Thompson PD, Udelson JE; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e292-e297. doi: 10.1161/CIR.0000000000000241.
9. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol. 1985;5(suppl):118B-121B.
10. Daida H, Allison TG, Squires RW, Miller TD, Gau GT. Peak exercise blood pressure stratified by age and gender in apparently healthy subjects. Mayo Clin Proc. 1996;71:445-452. doi: 10.1016/S0025-6196(11)64085-8.
11. Le VV, Mitiku T, Sungar G, Myers J, Froelicher V. The blood pressure response to dynamic exercise testing: a systematic review. Prog Cardiovasc Dis. 2008;51:135-160. doi: 10.1016/j.pcad.2008.07.001.
12. Blalock SE, Banka P, Geva T, Powell AJ, Zhou J, Prakash A. Interstudy variability in cardiac magnetic resonance imaging measurements of ventricular volume, mass, and ejection fraction in repaired tetralogy of Fallot: a prospective observational study. J Magn Reson Imaging. 2013;38:829-835. doi: 10.1002/jmri.24050.
13. Kempny A, Dimopoulos K, Uebing A, Moceri P, Swan L, Gatzoulis MA, Diller GP. Reference values for exercise limitations among adults with congenital heart disease: relation to activities of daily life: single centre experience and review of published data. Eur Heart J. 2012;33:1386-1396. doi: 10.1093/eurheartj/ehr461.
14. Bruaene AVD, Meester PD, Voigt JU, Delcroix M, Pasquet A, Backer JD, Pauw MD, Naeije R, Vachiéry JL, Paelinck BP, Morissens M, Budts W. Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with Eisenmenger syndrome. Int J Cardiol. 2013;168:1386-1392.
15. Inuzuka R, Diller GP, Borgia F, Benson L, Tay EL, Alonso-Gonzalez R, Silva M, Charalambides M, Swan L, Dimopoulos K, Gatzoulis MA. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259. doi: 10.1161/CIRCULATIONAHA.111.058719.
16. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M; for the Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114:48-54. doi: 10.1161/CIRCULATIONAHA.106.630715.
17. Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol. 2011;151:307-312. doi: 10.1016/j.ijcard.2010.05.066.
18. Müller J, Hess J, Hager A. Exercise performance and quality of life is more impaired in Eisenmenger syndrome than in complex cyanotic congenital heart disease with pulmonary stenosis. Int J Cardiol. 2011;150:177-181. doi: 10.1016/j.ijcard.2010.04.005.
19. Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, Budts W, Zwinderman AH, Van Gelder IC, Mulder BJ. Sudden cardiac death in adult congenital heart disease. Circulation. 2012;126:1944-1954. doi: 10.1161/CIRCULATIONAHA.112.104786.
20. Gallego P, Gonzalez AE, Sanchez-Recalde A, Peinado R, Polo L, Gomez-Rubin C, Lopez-Sendon JL, Oliver JM. Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. Am J Cardiol. 2012;110:109-117. doi: 10.1016/j.amjcard.2012.02.057.
21. Chiu SN, Wu MH, Su MJ, Wang JK, Lin MT, Chang CC, Hsu HW, Shen CT, Thériault O, Chahine M. Coexisting mutations/polymorphisms of the long QT syndrome genes in patients with repaired tetralogy of Fallot are associated with the risks of life-threatening events. Hum Genet. 2012;131:1295-1304. doi: 10.1007/s00439-012-1156-4.
22. Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Kay J, Valente AM, Earing MG, Lui G, Gersony DR, Cook S, Ting JG, Nickolaus MJ, Webb G, Landzberg MJ, Broberg CS; for the Alliance for Adult Research in Congenital Cardiology (AARCC). Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multiinstitutional study. Circulation. 2010;122:868-875. doi: 10.1161/CIRCULATIONAHA.109.928481.
23. Alonso-Gonzalez R, Borgia F, Diller GP, Inuzuka R, Kempny A, Martinez-Naharro A, Tutarel O, Marino P, Wustmann K, Charalambides M, Silva M, Swan L, Dimopoulos K, Gatzoulis MA. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013;127:882-890. doi: 10.1161/CIRCULATIONAHA.112.126755.
24. Marcuccio E, Arora G, Quivers E, Yurchak MK, McCaffrey F. Noninvasive measurement of cardiac output during exercise in children with tetralogy of Fallot. Pediatr Cardiol. 2012;33:1165-1170. doi: 10.1007/s00246-012-0276-x.
25. Lange R, Hörer J, Kostolny M, Cleuziou J, Vogt M, Busch R, Holper K, Meisner H, Hess J, Schreiber C. Presence of a ventricular septal defect and the Mustard operation are risk factors for late mortality after the atrial switch operation: thirty years of follow-up in 417 patients at a single center. Circulation. 2006;114:1905-1913. doi: 10.1161/CIRCULATIONAHA.105.606046.
26. Roubertie F, Thambo JB, Bretonneau A, Iriart X, Laborde N, Baudet E, Roques X. Late outcome of 132 Senning procedures after 20 years of follow-up. Ann Thorac Surg. 2011;92:2206-2213. doi: 10.1016/j. athoracsur.2011.06.024.
27. Schwerzmann M, Salehian O, Harris L, Siu SC, Williams WG, Webb GD, Colman JM, Redington A, Silversides CK. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur Heart J. 2009;30:1873-1879. doi: 10.1093/eurheartj/ehp179.
28. Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44:1095-1102. doi: 10.1016/j.jacc.2004.05.073.
29. Warnes CA. Transposition of the great arteries. Circulation. 2006;114:2699-2709. doi: 10.1161/CIRCULATIONAHA.105.592352.
30. Winter MM, van der Bom T, de Vries LC, Balducci A, Bouma BJ, Pieper PG, van Dijk AP, van der Plas MN, Picchio FM, Mulder BJ. Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial. Eur Heart J. 2012;33:1378-1385. doi: 10.1093/eurheartj/ehr396.
31. Sterrett LE, Ebenroth ES, Montgomery GS, Schamberger MS, Hurwitz RA. Pulmonary limitation to exercise after repair of D-transposition of the great vessels: atrial baffle versus arterial switch. Pediatr Cardiol. 2011;32:910-916. doi: 10.1007/s00246-011-0013-x.
32. Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36:255-261.
33. Grewal J, Crean A, Garceau P, Wald R, Woo A, Rakowski H, Silversides CK. Subaortic right ventricular characteristics and relationship to exercise capacity in congenitally corrected transposition of the great arteries. J Am Soc Echocardiogr. 2012;25:1215-1221. doi: 10.1016/j.echo.2012.08.014.
34. Gatlin S, Kalynych A, Sallee D, Campbell R. Detection of a coronary artery anomaly after a sudden cardiac arrest in a 17 year-old with D-transposition of the great arteries status post arterial switch operation: a case report. Congenit Heart Dis. 2011;6:384-388. doi: 10.1111/j.1747-0803.2011.00491.x.
35. Legendre A, Losay J, Touchot-Kone A, Serraf A, Belli E, Piot JD, Lambert V, Capderou A, Planche C. Coronary events after arterial switch operation for transposition of the great arteries. Circulation. 2003;108(suppl 1):II186-II190.
36. Fernandes SM, Alexander ME, Graham DA, Khairy P, Clair M, Rodriguez E, Pearson DD, Landzberg MJ, Rhodes J. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery. Congenit Heart Dis. 2011;6:294-303. doi: 10.1111/j.1747-0803.2011.00500.x.
37. Shafer KM, Garcia JA, Babb TG, Fixler DE, Ayers CR, Levine BD. The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation). J Am Coll Cardiol. 2012;60:2115-2121. doi: 10.1016/j.jacc.2012.08.970.
38. Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Müller J, Derrick G, Giannakoulas G, Khambadkone S, Lammers AE, Picchio FM, Gatzoulis MA, Hager A. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J. 2010;31:3073-3083. doi: 10.1093/eurheartj/ehq356.
39. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, Landzberg MJ. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85-92. doi: 10.1161/CIRCULATIONAHA.107.738559.
40. Brassard P, Bédard E, Jobin J, Rodés-Cabau J, Poirier P. Exercise capacity and impact of exercise training in patients after a Fontan procedure: a review. Can J Cardiol. 2006;22:489-495.
41. Cordina RL, O'Meagher S, Karmali A, Rae CL, Liess C, Kemp GJ, Puranik R, Singh N, Celermajer DS. Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. Int J Cardiol. 2013;168:780-788. doi: 10.1016/j. ijcard.2012.10.012.
42. Matthews IL, Fredriksen PM, Bjørnstad PG, Thaulow E, Gronn M. Reduced pulmonary function in children with the Fontan circulation affects their exercise capacity. Cardiol Young. 2006;16:261-267. doi: 10.1017/S1047951106000345.
43. Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NAM 3rd; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e315-e325. doi: 10.1161/CIR.0000000000000245.
44. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-1092. doi: 10.1161/CIRCULATIONAHA.108.804617.
45. Tuo G, Marasini M, Brunelli C, Zannini L, Balbi M. Incidence and clinical relevance of primary congenital anomalies of the coronary arteries in children and adults. Cardiol Young. 2012:1-6
46. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493-1501.
47. De Rosa G, Piastra M, Pardeo M, Caresta E, Capelli A. Exercise-unrelated sudden death as the first event of anomalous origin of the left coronary artery from the right aortic sinus. J Emerg Med. 2005;29:437-441. doi: 10.1016/j.jemermed.2005.07.001.
48. Edwards CP, Yavari A, Sheppard MN, Sharma S. Anomalous coronary origin: the challenge in preventing exercise-related sudden cardiac death. Br J Sports Med. 2010;44:895-897. doi: 10.1136/bjsm.2008.054387.
49. Frommelt PC. Congenital coronary artery abnormalities predisposing to sudden cardiac death. Pacing Clin Electrophysiol. 2009;32(suppl 2):S63-S66. doi: 10.1111/j.1540-8159.2009.02387.x.
50. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Circulation. 2008;118:e714-e833. doi: 10.1161/CIRCULATIONAHA.108.190690.
51. Graham TP Jr, Driscoll DJ, Gersony WM, Newburger JW, Rocchini A, Towbin JA. Task Force 2: congenital heart disease. J Am Coll Cardiol. 2005;45:1326-1333. doi: 10.1016/j.jacc.2005.02.009.